Answers are grounded in this paper and cite their sources.
In this review we describe current strategies for adenoviral mediated gene transfer (AMGT) and adeno-associated viral mediated gene transfer (AAVMGT). We consider the structure and molecular biology of adenoviruses and adeno-associated viruses and detail the current advantages and disadvantages of AMGT and AAVMGT. Potential solutions to some of the specific drawbacks to AMGT, including the development of new vectors, addition of gp19k, organoides, and the use of non-human adenoviral vectors, are discussed.
No takes yet. Share an insight, caveat, or question.
Kremer et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: